15.09.2021Rappta Therapeutics Appoints Sunjeet Sawhney as Chief Executive Officer

Press Release
09.09.2021Eloxx Pharmaceuticals Announces Fast Track Designation for ELX-02 for the Treatment of Cystic Fibrosis Patients with Nonsense Mutations

Press Release
02.09.2021Orphalan announces FDA acceptance for filing of New Drug Application (NDA) for trientine tetrahydrochloride (TETA 4HCl) for the treatment of Wilson’s Disease

Press Release
13.07.2021Artax Biopharma Granted MHRA Clinical Trial Authorization for AX-158

Press Release
07.07.2021NeRRe Therapeutics raises £20 million in a Series B2 financing round

Press Release
28.06.2021Amphista Therapeutics Expands Research Team by Appointing Martin O’Rourke as Head of Drug Discovery and James Osborne as Director of Chemistry

Press Release
23.06.2021Aleta Biotherapeutics and Cancer Research UK collaborate to advance blood cancer therapy into the clinic

Press Release
17.06.2021Aura Biosciences Assembles New Bladder Cancer Focused Scientific Advisory Board

Press Release
08.06.2021Aura Biosciences Appoints Sapna Srivastava, Ph.D., to its Board of Directors

In The News
14.04.2021Highlight Therapeutics to present data from Phase 2 immunotherapy studies of liver metastases and melanoma data at AACR Virtual Annual Meeting 202

Press Release